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Neisseria gonorrhoeae (Ngo) has developed multiple immune evasion mechanisms involving the innate and adaptive immune
responses. Recent findings have reported that Ngo reduces the IL-1𝛽 secretion of infected human monocyte-derived macrophages
(MDM). Here, we investigate the role of adenosine triphosphate (ATP) in production and release of IL-1𝛽 in Ngo-infected MDM.
We found that the exposure of Ngo-infected MDM to ATP increases IL-1𝛽 levels about ten times compared with unexposed Ngo-
infected MDM (𝑃 < 0.01). However, we did not observe any changes in inflammasome transcriptional activation of speck-like
protein containing a caspase recruitment domain (CARD) (ASC, 𝑃 > 0.05) and caspase-1 (CASP1, 𝑃 > 0.05). In addition, ATP was
not able to modify caspase-1 activity in Ngo-infected MDM but was able to increase pyroptosis (𝑃 > 0.01). Notably ATP treatment
defined an increase of positive staining for IL-1𝛽 with a distinctive intracellular pattern of distribution. Collectively, these data
demonstrate that ATP induces IL-1𝛽 secretion by a mechanism not related to the NLRP3/ASC/caspase-1 axis and likely is acting at
the level of vesicle trafficking or pore formation.
1. Introduction
Neisseria gonorrhoeae (Ngo) or gonococcus, a Gram-negative
diplococcus, is the etiological agent of the sexually transmit-
ted bacterial infection (STI) gonorrhoea. Gonorrhea is the
secondmost frequent STI worldwide, where the total number
of new cases of gonorrhea in adults was estimated to be
106.1 million cases out of 498.9 million with STI [1]. Clinical
data also indicates that previous gonococcal infections do
not improve immune response in patients with reinfection,
which suggest that immunological memory is not induced
by gonococcus [2]. Since the ineffective immune response
against gonococcus ismultifactorial, it has been hypothesized
that it could be the sumof differentmechanisms. One of them
may be related to genital tissue properties, such as immune
privileged site in the female tract [3, 4], while the other
could involve evasion mechanisms intrinsically developed
by the bacteria, such as phase and antigenic variations [5],
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epitopemimicry [6], and phagosome subversion to overcome
immune defence [7]. On the other hand, Ngo has several
mechanisms for evading complement-mediated defences,
such as LOS sialylation [8] and binding of PorB molecules to
the complement cascade inhibitors factor H and complement
factor 4b-binding protein (C4BP) [9].
The current data suggest that Ngo is able to suppress
the protective innate cellular immune response at different
levels. Even though phagocytosis by neutrophils (PMN) is
generally a dead end for bacteria, it has been demonstrated
that the number of intracellular Ngo cells and the number
of bacteria per intracellular phagosome inside neutrophils
increase over time [10–12].Moreover,Ngo usemultiplemech-
anisms to defend themselves against other ROS; nonoxidative
antibacterial factors of PMN must act on the bacteria, which
implies that these factors are not sufficient to clear infection
[13]. On the other hand, macrophages (MΦ) and dendritic
cells (DC) are critical cells in the innate immune response;
it has been showed that Ngo potently inhibits the ability
of antigen-primed bone-marrow-derived DC (BMDC) to
trigger T-cell proliferation by inducing expression of both
immunosuppressive cytokines and tolerance-inducing cell
surface protein [14]. Recent findings of our laboratory have
demonstrated that human monocyte-derived macrophages
(MDM)were induced to aM2profilewhen theywere infected
with Ngo. No significant differences were observed in IL-
1𝛽 levels in comparison to gonococcus-treated macrophages
and M0-macrophages suggesting that Ngo could trigger
insufficient IL-1𝛽 levels to activate innate immune response,
which leads to chronic inflammatory condition with no
pathogen destruction [15].
IL-1𝛽 is described as a proinflammatory cytokine that
is crucial for host-defense responses to infection and injury
[16]. IL-1𝛽 needs two independent signals to be properly
active and functionally released: a priming step where a
first signal in response to pathogen associated molecular
patterns (PAMP) induces pro-IL-1𝛽 expression [17] and a
second signal which transforms pro-IL-1𝛽 in its mature and
functional form (IL-1𝛽) for proper release.This second signal
is mediated by a protein complex named inflammasome,
which prompts activation of the IL-1𝛽 converting enzyme
caspase-1 [18], although it has been shown in other cells like
PMN that production of IL-1𝛽 is not entirely dependent on
caspase-1 and several serine proteases including CG, NE, and
PR3 can also process pro-IL-1𝛽 [19].
In macrophages, multiple distinct bacterial products
signals stimulate the NLRP3 inflammasome, resulting in the
proteolytic activation of caspase-1 [20–22]. NLRP3 has a
tripartite structurewith a PAMP/danger associatedmolecular
patterns (DAMP) sensing C-terminal leucine-rich repeat
(LRR), a central nucleotide binding (or NACHT) domain,
and an N-terminal pyrin domain (PYD) [23]. The PYD
domain of NLRP3 recruits the adaptor molecule apoptosis-
associated speck-like protein containing a caspase recruit-
ment domain (ASC), which recruits pro-caspase-1 and pro-
duces caspase-1 activation [23].
Many pathogens have different mechanisms to disrupt
inflammasome activation and therefore IL-1𝛽 production
[24]. Thus, the searching for strategies to overcome this
disruption is an important goal to be addressed. To date, three
models of NLRP3 activation in response to microbial ligands
have been proposed: K+ efflux, lysosomal rupture, and ROS
production [25–27]. Additionally, endogenous DAMP such
as extracellular ATP on macrophages produces a variety of
cellular effects, including amaturation and release of IL-1𝛽 by
inflammasome activation [28]. ATP can be secreted under a
broad range of conditions including antigen presentation and
macrophage interaction with bacteria or microbial products
such as LPS [29]. In vitro studies have demonstrated that ATP
ligation of the P2X7 also stimulates killing of intracellular
chlamydiae and mycobacteria in infected macrophages [30–
32]. In addition, gingival epithelial cells infected with P.
gingivalis secrete IL-1𝛽 only after stimulation with extracel-
lular ATP [33]. Therefore, we tested the hypothesis that the
addition of an exogenous source of ATP promotes the IL-
1𝛽 processing and release during Ngo infection in human
monocyte-derived macrophages (MDM). We demonstrated
that ATP stimulation increases the secretion of IL-1𝛽 in
Ngo-infected MDM. Interestingly, high levels of IL-1𝛽 did
not correlate with the activation of inflammasome-mediated
caspase-1, as previously observed in other microorganisms
[33–35] suggesting that ATP-induced IL-1𝛽 secretion could
be acting at the level of mechanisms related to vesicle
trafficking or pore formation.
2. Materials and Methods
2.1. Blood Samples. Human buffy coats were provided by
volunteers after informed consent. The study was approved
by the Scientific Ethics Committee of Hospital Cl´ınico
Universidad de Chile (approval number 58). After sample
collection, a trial number was assigned to each donor with
their demographic data and the database was anonymised.
2.2. Bacteria and Culture Conditions. Neisseria gonorrhoeae
P9-17 strain used in this study was kindly provided by Dr.
Myron Christodoulides (University of Southampton, UK).
Gonococcal vials were taken from frozen stocks, plated
on Thayer Martin plates (LaboratorioLinsan, Chile), and
cultured at 37∘C in 5% CO2 for 18 to 20 hours. Single colonies
with Pil+ Opa+ phenotype were reisolated for subsequent
experiments.
2.3. Monocyte-Derived Macrophage (MDM) Generation.
Human monocytes were obtained from normal blood
donor buffy coats by two-step gradient centrifugation fol-
lowed by an additional step using RosetteSep Human
Monocyte Enrichment Cocktail (STEMCELL Technologies).
Monocyte-derived macrophages (MDM) were obtained by
culturing monocytes (84% CD14+) for 7 days in RPMI 1640
(GIBCO, Invitrogen Corporation) supplemented with 10%
FBS (HyClone), 50U/mL penicillin, 50𝜇g/mL streptomycin
(Gibco Invitrogen), and 50 ng/mL ofM-CSF (MiltenyiBiotec)
in 6-well plates at a density of 2 × 106 cells per well.
2.4. ATP Solution Preparation. The necessary amount of
ATP (product number A6419 Sigma-Aldrich, MO, USA)
for experiment was weighed in a Eppendorf tube. Ten
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minutes before cells stimulation, ATP was diluted in non-
supplemented RPMI-1640 medium to generate a 10mMATP
solution. Then ATP solution was filtered using syringe filter
(pore size 0.2 𝜇m) and it was immediately added to the cells
to reach a 5mM concentration.
2.5. MDM Infection and Treatment with ATP. Bacterial
suspensions were prepared in 1mL serum-free RPMI1640
medium. MDM were infected with Ngo at a multiplicity of
infection (MOI) of 100 for 4 hours at 37∘C and 5% CO2.
Then cultures were treated with gentamicin (100 𝜇g/mL)
(Invitrogen Corp., Carlsbad, CA) to kill extracellular bacteria
for 2 h at 37∘C and 5% CO2. Medium was replaced by
nonsupplemented (serum-free and antibiotic-free) RPMI
and then 5mM ATP (Sigma-Aldrich, MO, USA) was added
and incubated for 30 minutes at 37∘C 5% CO2. Finally, the
supernatants were collected for IL-1𝛽, while cells were lysed
for RNA extraction.
2.6. Measurement of Secreted IL-1𝛽. IL-1𝛽 levels were mea-
sured in supernatants immediately after 30-minute treat-
ment with ATP by enzyme-linked immunosorbent assays
using ELISA Ready-SET-Go! (eBioscience, USA, sensitivity
2 pg/mL), according to the manufacturer’s instructions.
2.7. Quantitative Real-Time PCR (qRT-PCR). Total RNA was
extracted (purified) from MDM as described previously
[36]. Reverse transcription (5 𝜇g) was performed using the
Transcriptor First-Strand cDNA synthesis kit following the
manufacturer’s recommendations (Roche Applied Science,
Mannheim, Germany). To quantify the mRNA expression
of IL-1𝛽, NLRP3, ASC, and CASP-1, 50 ng of cDNA was
amplified by quantitative real-timePCRusing the appropriate
primers and the SybrGreen Master Mix (Fermentas) in a
StepOne Real-Time PCR System (Applied Biosystems,
California, USA). The cycle program used was 95∘C for
10min, followed by 40 cycles of 95∘C for 15 s, 60∘C for 30 s,
and 72∘C for 30 s. Primer sequences were as follows: 5󸀠-
CTTCCTTTCCAGTTTGCTGC-3󸀠 forward and 5󸀠-TCT-
CGCAGTCCACTTCCTTT-3󸀠 reverse for NLRP3, 5󸀠-AGT-
TTCACACCAGCCTGGAA-3󸀠 forward and 5󸀠-TTTTCA-
AGCTGGCTTTTCGT-3󸀠 reverse for ASC, 5󸀠-GCCCAA-
GTTTGAAGGACAAA-3󸀠 forward and 5󸀠-GGTGTGGAA-
GAGCAGAAAGC-3󸀠 reverse for CASP-1, 5󸀠-CTGTCCTGC-
GTGTTGAAAGA-3󸀠 forward and 5󸀠-TTGGGTAATTTT-
TGGGATCTACA-3󸀠 reverse for IL-1𝛽, and 5󸀠-CTAACA-
CGGGAAACCTCAC-3󸀠 forward and 5󸀠-CGCTCCACC-
AACTAAGAACG-3󸀠 reverse for 18S. The fold change in
expression of the target gene relative to the 18S endogenous
control was set at 2−ΔΔCt, where ΔΔCt = (CtTarget − Ct18S)
stimulated − (CtTarget − Ct18S) unstimulated.
2.8. Detection of Enzymatically Active Caspase-1 and Apop-
tosis by Flow Cytometry. A FAM-FLICA caspase-1 assay
kit (ImmunoChemistry Technologies) was used to detect
caspase-1 enzymatic activity according to the manufacturer’s
instructions. FLICA was diluted and added to wells con-
taining infected, ATP-treated or nontreated cells. The cells
were cultured for 4 hours and MDMwere then collected and
subjected to flow-cytometric analysis (Facscalibur, Becton-
Dickinson, San Diego, CA, USA) to quantify the percentage
of FAM-FLICA-positive MDM. Apoptosis of MDM cells was
measured using an FITC Annexin V Apoptosis Detection Kit
with 7-AAD (BioLegend). Data analysis was performed using
WinMDI 2.8 (freeware).
2.9. Immunofluorescence Microscopy Analysis. Macrophages
were grown on 12 mm coverslips in 24-well plates and
were treated using same conditions of cell culture previously
described. After 30 minutes of ATP stimulation, cells super-
natant was removed and coverslips were washed twice with
sterile PBS 1x and then cells were fixedwith 4%paraformalde-
hyde in 100mM PIPES buffer pH 6.8, containing 40mM
KOH, 2mM EGTA, and 2mM MgCl2 for 30 minutes.
Then, cells were washed three times with washing solution
(50mMTris buffer pH 7.6 containing 0.15N NaCl and 0.1%
sodium azide) and permeabilized with 0.1% Triton X-100 in
washing solution for 10min, washed twice, and then blocked
with 2% bovine serum albumin for 60min. Intracellular IL-
1𝛽 was evaluated by staining cells with an anti-IL-1𝛽 Rb
pAb at 1 : 100 dilution (ab2105, abcam, USA), followed by
a goat anti-rabbit IgG (H+L) secondary antibody, Alexa
Fluor 488 conjugate (A11008, Life Technologies) at 1 : 100
dilution.Nuclear stainingwas carried out usingDAPI (D9542
Sigma-Aldrich, St. Louis,MO). Coverslips were washed twice
and mounted on microscope slides with DAKO fluorescent
mountingmedium (DakoNorthAmerica Inc., CA,USA) and
samples were visualized with a confocal microscopy (Carl
Zeiss, model LSM700).
3. Results
3.1. N. gonorrhoeae Induces IL-1𝛽 Transcription but Inhibits
IL-1𝛽 Secretion in MDM. Previous findings of our laboratory
showed that IL-1𝛽present in supernatants fromNgo- infected
macrophages at differentMOIs was not significantly different
from nonstimulated MDM [15]. To further explore in those
results, we aimed to detect the presence of IL-1𝛽 from MDM
infected with Ngo at 100MOI. As shown in Figure 1(a),
macrophages infected with Ngo did not show more IL-
1𝛽 secretion than noninfected macrophages. Indeed, IL-1𝛽
secretion by macrophages exposed to LPS was much more
than IL-1𝛽 secreted by Ngo-infected macrophages. However,
when total mRNA levels of pro-IL-1𝛽were assessed by qPCR,
we observed that pro-IL-1𝛽 RNA levels were highly induced
in response to gonococcal infection (Figure 1(b)), indicating
that Ngo is able to trigger the signaling pathway to start pro-
IL-1𝛽 synthesis.
3.2. ATP Increases IL-1𝛽 Levels in Culture Supernatants from
Ngo-Infected Macrophages. Since the synthesis of mature
IL-1𝛽 depends on the activation of NLRP3 inflammasome
signaling pathway as a second signal [37], we aimed to
stimulate the NLRP3 inflammasome in Ngo-infected MDM
using a cognate agonist (ATP) [38], to establish whether
gonococcus are modifying NLRP3 inflammasome activity.
Our results showed that the low levels of secreted IL-
1𝛽 from Ngo-infected MDM were increased in presence
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Figure 1: Ngo inhibits IL-1𝛽 levels in culture supernatants from infected MDM but is not able to inhibit IL-1𝛽 mRNA expression. MDM
cells were infected with Ngo and then cytokine and RNA levels were evaluated after 30 minutes after infection. (a) Detection of IL-1𝛽 in
culture supernatant by ELISA. (b) Transcriptional cytokine analysis by qRT-PCR. Results represent fold changes in transcript levels between
no infected MDM and MDM infected with Ngo or treated with LPS. Data obtained are expressed as the mean ± SD and represent at least 6
independent experiments. ∗𝑃 < 0.05; ∗∗∗∗𝑃 < 0.0001.
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Figure 2: ATP treatment increases IL-1𝛽 levels by Ngo-infected
MDM. MDM cells were infected with Ngo and then treated with
ATP (5mM) for 30 minutes. Culture supernatants were collected
for measurement of IL-1𝛽 by ELISA. Data represent at least 4
independent experiments; bars indicate SD; ∗∗∗𝑃 < 0.001; ∗∗∗∗𝑃 <
0.0001.
of ATP (Figure 2). The use of ATP was able to induce a
similar cytokine production in Ngo-infected MDM as LPS
stimulated MDM. It suggests that Ngo apparently is able to
prevent inflammasome activation.
3.3. ATP Does Not Activate NLRP3 Inflammasome RNA
Expression in Ngo-Infected MDM. Since one of the strate-
gies adopted by bacterial pathogens is the inflammasome
subversion [21] and the use of ATP contributes to the host
immune response against intracellular bacteria, through its
ability to stimulate P2X7-dependent IL-1𝛽 secretion [29],
we decided to study whether inflammasome components
NLRP3, ASC, and caspase-1 (CASP-1) might be modified by
the ATP treatment in infected MDM. Data obtained from 4
independent experiments showed thatATPonlymodified the
RNA expression levels ofNLRP3 in infectedMDM, while the
levels of ASC and CASP-1 showed no significant differences
with nonstimulated infected cells (Table 1).
3.4. ATP Does Not Modify Caspase-1 Activity in Ngo-Infected
MDM but Is Able to Increase Pyroptosis. Caspase-1 activation
is necessary to process pro-IL-1𝛽 onto mature IL-1𝛽, but
ATP was not able to produce transcriptional activation of
CASP-1; thus we assessed if ATP is able to modify caspase-1
activity in Ngo-infected MDM, using a fluorescent inhibitor
probe FAM-YVAD-FMK to label active caspase-1 enzyme.
Data obtained from 3 independent experiments showed
that ATP treatment of Ngo-infected MDM was not able to
induce the activation of caspase-1 in infected cells (Figure 3).
Activation of caspase-1 also triggers a form of cell death,
known as pyroptosis [39]. Although trypan blue staining
showed that most cells were viable after infection and ATP
treatment, we performed a FITC Annexin V (AV) with 7-
aminoactinomycin (7-AAD) Apoptosis Detection assay to
monitor ATP-induced cell pyroptosis. Considering that the
feature of pyroptosis is the positive staining with AV in
contrast to negative 7-AAD staining [40], we compared the
percentage of AV+ 7-AAD− cells. ATP was able to induce
an early stage of apoptosis in gonococcus-infected MDM
(Figure 4).
3.5. ATP Affects the Intracellular Distribution of IL-1𝛽 in
Ngo-InfectedMDMCells. Since NLRP3 inflammasome is not
involved in the ATP-induced IL-1𝛽 secretion in gonococcus-
infected MDM, we aimed to observe the ability of ATP
to induce a nonclassical IL-1𝛽 secretion by microvesicles
formation [41]. Ngo-infected MDM treated with ATP were
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Table 1: Transcriptional activation of inflammasome-associated genes in MDM.
Gene
designation Protein
Fold changea
MDM+Ngo MDM+Ngo+ATP
NLRP3 NLR family, pyrin domain-containing protein 3
0.67 3.45†
ASC
Apoptosis-associated speck-like
protein containing a caspase
recruitment domain
0.54 0.63
CASP1 Caspase-1 2.1 2.6
aValues represent fold changes in transcript levels between MDM infected with Neisseria gonorrhoeae and MDM infected with Neisseria gonorrhoeae treated
with ATP. †𝑃 < 0.05. Mann–Whitney 𝑈 test.
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Figure 3: ATP treatment does not modify caspase-1 activity in Ngo-infected MDM.The fluorescent labeled probe of caspase-1 FAM-YVAD-
FMK (FAM-FITC) was incubated with uninfectedMDM, gonococcus-infectedMDM (Ngo+MDM), or gonococcus-infectedMDMandATP
(Ngo+MDM+ATP). After washing, the fluorescent intensity retained by the MDM was determined by flow cytometry. (a) Representative
histograms from one assay are shown. (b) Percentage of positive FAM cells under different conditions. Data obtained are expressed as the
mean ± SD and represent at least three independent experiments.
observed for intracellular distribution of mature IL-1𝛽 by
immunofluorescence using confocal microscopy. Notably,
ATP treatment of Ngo-infected MDM defined an increase
of positive staining for IL-1𝛽 with a distinctive pattern
of distribution (Figure 5(c)) as a focus formation towards
membrane.
4. Discussion
The current data suggest that Ngo produce lack of induction
of protective immune response inmacrophages and dendritic
cell [14, 15, 42]. Recent findings of our laboratory have
recognized that MDM are induced to a M2 profile when they
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Figure 4: ATP treatment is able to increase apoptosis in Ngo-infected MDM. FITC Annexin V with 7-AAD staining was performed and
the MDM population was determined by flow cytometry. (a) Representatives dot plot from one assay are shown. (b) Percentage of positive
AnnexinV and 7-AADcells under different conditions.Data obtained are expressed as themean± SD and represent at least three independent
experiments. ∗∗𝑃 < 0.01.
are infected with Ngo and do not reach significant differences
in IL-1𝛽 levels between gonococcus-treated macrophages
and M0-macrophages [15]. In this work, we confirmed
the lower levels of IL-1𝛽 in Ngo-infected human MDM
(Figure 1(a)). Our data differ with those reported by Duncan
et al. which showed that Ngo can promote NLRP3 activation
and IL-1𝛽 secretion in human macrophages THP-1 cells
[43]. This discrepancy might be explained by the remarkable
difference between THP-1 cell line (monocytic nature) [44]
and macrophages. The increase in the constitutive caspase-
1 activation [45] and subsequent IL-1𝛽 secretion by mono-
cytes following TLR stimulation is well recognized, whereas
macrophages require a second signal [46]. Moreover, we
showed that macrophages skewed from the M1 to M2 states,
when infected with Ngo, have low levels of the Toll-like
receptor-4 (TLR-4) [15], which has been shown to play a key
role in the induction of inflammatory pathways [47].
The cytokine IL-1𝛽 is controlled by two checkpoints:
transcription and maturation and release [48]. Our first
results showed lower levels of mature IL-1𝛽 in Ngo-
infected human MDM supernatants. However, when we
looked at transcript level, we showed a sizable induction
of IL-1𝛽 RNA upon gonococcal infection (Figure 1(b)).
The differences in transcription versus translation of IL-
1𝛽 induced by gonococcus in MDM cells could be due to
disruption in inflammasome activity as shown in others
pathogens [20]. Since ATP contributes to the host immune
response against intracellular bacteria through its ability to
stimulate IL-1𝛽 secretion [29], we showed that ATP treatment
of gonococcus-infected MDM cells is able to restore IL-
1𝛽 secretion (Figure 2) as shown in gingival epithelial cells
infected with P. gingivalis, which only secrete IL-1𝛽 after
stimulation with extracellular ATP [33]. After having estab-
lished the effect of ATP on IL-1𝛽 production by gonococcus-
treatedMDM, we examined the mRNA expression of NLRP3
inflammasome-associated genes: NLRP3, ASC, and CASP-1
to assess inflammasome transcriptional activity in presence
of ATP. Only the NLRP3 transcript was upregulated in Ngo-
infected MDM cells treated with ATP (Table 1). To date,
the exact action mechanism of ATP on transcription of
inflammasome is unknown. However, it is not surprising that
expression of NLRP3 was affected by ATP, because the ATP
releasemay act as a danger signal tomobilize intracellular cal-
cium, further modulating NF-𝜅B activation acting through
a P2Y receptor/phospholipase-C/calcium signaling pathway
[49]. In this context, the existence of binding sequences to
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Figure 5: ATP modulates IL-1𝛽 distribution in Ngo-infected MDM cells. IL-1𝛽 expression was analyzed by confocal microscopy. (a) MDM
cells, (b) Ngo-infected MDM. (c) Ngo-infected MDM treated with ATP. Images of IL-1𝛽 (green) and DAPI (blue). Arrow pointed IL-1𝛽
concentration. Scale bars 10 𝜇m.
NF-𝜅B has been demonstrated in the NLRP3 promoter in
murine macrophages [50].
Interestingly, we did not detect any changes in transcrip-
tion levels of ASC and CASP-1 in Ngo-infected macrophages
treated with ATP (Table 1). The nonchange in levels of
expression of ASC and CASP-1 could be explained because
unlike NLRP3, its transcriptional regulation is not associated
with MyD88 and NF-𝜅B [51]. In line with this, we think
that the absence of changes in transcription level of ASC
could be affecting caspase-1 activity in response to ATP,
because the function of adaptor protein ASC is enabling
the activation of caspase-1 in inflammasome. Indeed, Asc−/−
macrophages secreted much less mature IL-1𝛽 than their
wild-type counterparts in S. typhimurium-induced caspase-
1 activation model [52].
Although we did not observe changes in transcription
levels of CASP-1, we assessed the caspase-1 activity in Ngo-
infected MDM cells treated with ATP. We did not observe
any changes in caspase-1 activity between infectedMDMcells
with or without ATP. Interestingly, in our model of MDM
cells, infection with Ngo does not induce pyroptosis com-
pared with uninfected MDM cells, unlike what is reported
by Duncan et al., who showed that Ngo infection promotes
NLRP3-dependent THP-1 cell death via pyronecrosis [43].
However, when infected MDM cells were treated with ATP,
we observed an induction of early apoptotic cells (AV+
7AAD−). Even though pyroptosis is caspase-1-dependent,
we do not discard other mechanisms that induce apoptosis.
As showed by previous works, extracellular ATP induces
apoptotic signaling in different cells types using different
pathways that link purinergic receptors to induce apoptosis
and necrosis [53–55].
Our results showed that ATP was not able to acti-
vate caspase-1 at RNA and protein level in Ngo-infected
macrophages (Table 1 and Figure 3). Since pro-IL-1𝛽 and pro-
IL-18 are the substrates in vitro and in vivo of caspase-1 [56],
we hypothesize that IL-1𝛽 secretion induced by ATP in Ngo-
infected macrophages could be at an alternative level from
pro-IL-1𝛽 processing by NLRP3 inflammasome. In a recent
report studying Porphyromonas gingivalis-infected mice
macrophages, IL-1𝛽 secretion was inhibited by the pathogen
fimbriae through inflammasome independent P2X7R mech-
anisms, suggesting that, in this pathological context, the IL-
1𝛽 absence was due to unknown secretory signaling pathway
involving P2X7R [57].
Using confocal microscopy, we attempted to localize the
presence and distribution of mature IL-1𝛽, where it was
clearly visible that Ngo-infected MDM induced a pattern of
the mature IL-1𝛽 arrangement with stained points dispersed
in the cells. This dispersion of mature IL-1𝛽 as stained
points was changed to concentrated and polarized points
(Figure 5). Since the secretion mechanism to IL-1𝛽 does not
correspond to the classic cytokine ER-Golgi pathway [58]
and its secretion could be carried by intracellular vesicles,
secretion lysosome exocytosis, or direct passing through
the cellular membrane [41], we speculate that one of the
possibilities in the downmodulation of IL-1𝛽 secretion by
gonococcus could be due to a mechanism related to pore
formation. Indeed, during pyroptosis, pores open in the cell
membrane and this structural change could promote the
cellular release of interleukin-1𝛽 [39]. Moreover, as shown
by Pelegrin and Surprenant, pannexin-1 (Panx1) could be
a functional link between P2X7R-activated large pore for-
mation and cytokine release in macrophage. In this sense,
the activation of P2X7-receptor triggers the recruitment of
an accessory pore-forming mechanism [59, 60]; the Panx1
protein knockdown and panx1-mimetic inhibitory peptide
are able to block ATP-mediated IL-1𝛽 release in mouse and
human macrophage [61]. This issue was not assessed in this
work and further studies are required to investigate this
phenomenon.
5. Conclusion
In this work, we demonstrated that N. gonorrhoeae probably
evades host defence by not activating the NLRP3 inflamma-
some in macrophages and showed that extracellular ATP is
likely to act at the level of vesicle trafficking or pore formation.
8 Mediators of Inflammation
A better understanding of mechanisms that produce the IL-
1𝛽 downmodulation by gonococcus will further contribute
to the advance of our knowledge on N. gonorrhoeae patho-
genesis and let us find a therapeutic strategy for treatment of
gonococcus infection.
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